Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.
about
Polymorphic acetylation of sulphamethazine in a Zimbabwe population.Acetylator phenotypes in Papua New Guinea.N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosisShould we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and CaucasiansHeterocyclic amine intake, smoking, cytochrome P450 1A2 and N-acetylation phenotypes, and risk of colorectal adenoma in a multiethnic population.Interaction between Red Meat Intake and NAT2 Genotype in Increasing the Risk of Colorectal Cancer in Japanese and African AmericansGlobal Urine Metabolomics in Patients Treated with First-Line Tuberculosis Drugs and Identification of a Novel Metabolite of EthambutolNAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapyAntituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism.Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology.Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimensLack of correlation between acetylator status and the production of the acetyl metabolite of acebutolol in man.
P2860
Q33592378-88942F6D-4067-4969-A4B6-4D3EBA376172Q33670130-517B75B5-3AFF-4EA4-8FDF-05575C08B45DQ33768531-668D1F0B-0593-467B-8C23-69DA3340DDC9Q33770163-C0221028-9D5D-41A4-BF03-D6EF5A3C97FDQ34450224-B1D5919F-47D3-4349-9586-6A44566F983DQ34622551-82254BC1-6F2F-44B5-B19A-A80DCBA131F0Q35817545-010C8E85-1E7E-446E-899D-918441DDD3E6Q35873064-ED6815CB-B392-43AB-BA3D-A274FCA43C11Q35911355-E6322E6D-21C5-4485-82FB-629FFD1B1801Q36809405-17F952F3-0ED2-4B26-BD42-066426D07C07Q37268068-89329645-E8AA-4684-AA2C-6247A232D0ACQ40530680-EADD6286-EFE4-4914-8437-F701B07B2EA5Q41844281-3280962F-100B-4617-9AE0-E121D732E95AQ43251614-F2499D01-7253-41A0-8906-55338A1DC6F2
P2860
Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Variations between individuals ...... ent of pulmonary tuberculosis.
@en
type
label
Variations between individuals ...... ent of pulmonary tuberculosis.
@en
prefLabel
Variations between individuals ...... ent of pulmonary tuberculosis.
@en
P1476
Variations between individuals ...... ent of pulmonary tuberculosis.
@en
P2093
P304
P407
P433
P577
1976-05-01T00:00:00Z